A real-world disproportionality analysis of Everolimus: data mining of the public version of FDA adverse event reporting system

Conclusion: This study provided novel insights into the monitoring, surveillance, and management of adverse drug reaction associated with Everolimus. The outcome of serious adverse events and the corresponding detection signals, as well as the unexpected significant adverse events signals are worthy of attention in order to improving clinical medication safety during treatment of Everolimus.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research